Check Cap Ltd (CHEK) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2023 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Check Cap Ltd  (NASDAQ: CHEK)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Check Cap Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Check Cap Ltd's ROI in the fourth quarter of 2025?
Check Cap Ltd achieved a return on average invested assets (ROI) of 117.66 % in its fourth quarter of 2025, this is above CHEK's average return on investment of 101.17%.
Check Cap Ltd invested over the 12 months ending in its fourth quarter of 2025 $4 million

ROI fell compared to the third quarter of 2025, despite the net income growth of % from the third quarter of 2025.

Within the Healthcare sector 19 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 56.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM -79.63 % -90.88 % -74.76 % -63.05 % -53.88 %
Y / Y Net Income Change TTM -33.74 % 125.58 % 125.58 % -27.11 % -67.3 %
Investment (TTM) in Millions 3 3 4 3 -1
Return On Investment (TTM) 117.66 % 764.91 % 242.93 % 87.53 % -
CHEK's Overall Ranking # 56 # # # #
Seq. Investment Change TTM 53.19 % -68.24 % -40.79 % -29.3 % -31.41 %
Seq. Net Income Change TTM -76.43 % 0 % 64.34 % 71.09 % -19.77 %
Net Income (TTM) in Millions 4 18 18 11 6

CHEK Company Profile >> Back to CHEK Roi Comparisons >> See Annual CHEK Return On Investment



Return On Investment CHEK's Ranking
Within: No.
Industry # 2
Sector # 20
Overall # 56

Return On Investment Statistics
High Average Low
208.78 %
101.17 %
33.33 %
(Dec 31 2019)   (Dec 31 2021)



  News about Check Cap Ltd Return on Investment ROI

Check-Cap Ltd Achieves 46.25% ROI in Q4 2022, Trails Behind Peers in Healthcare Sector Rankings

December 22, 2023


December 22, 2023 - Symetryx Corporation (Symetryx), a Canadian venture company, successfully elected all the director nominees proposed by Symetryx at Check-Cap Ltd s (NASDAQ: CHEK) Annual General Meeting, receiving overwhelming support from shareholders. This decisive vote signals a significant endorsement of Symetryx s campaign and its mission to drive positive change within the company.
While Check-Cap Ltd witnessed a respectable return on average invested assets (ROI) of 46.25% in the fourth quarter of 2022, it falls short of the company s average return on investment of 103.45%. However, it is worth noting that there has been an improvement in ROI compared to the third quarter of 2022, where it stood at 39.19%, following growth in net income.





Financial Statements
Check Cap Ltd's IV. Quarter Investments $ 3 Millions CHEK's Balance sheet
Check Cap Ltd's IV. Quarter Income $ 4 Millions Quarterly CHEK's Income Statement
CHEK's Income by Division See CHEK's Income by Division


CHEK Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 3 -1 24 41 52
Y / Y Investment Growth - - -42.66 % -19.97 % 209.89 %
Net Income in Millions 4 -25 -18 -19 17
Y / Y Net Income Growth - - - - 24.24 %
Annual Return On Investment 120.45 % - -74.17 % -46.25 % 33.33 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 120.45 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CHEK's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CHEK's Competitors
Subscribers only: Roi for Check Cap Ltd's Suppliers
Subscribers only: Return On Investment for CHEK's Customers

Other Ratios
CHEK's Roa CHEK's Inventory Turnover Ratio CHEK's Growth Rates CHEK's Dividend Statistics
CHEK's Profitability Ratios CHEK's Asset Turnover Ratio CHEK's Dividend Growth
CHEK's Roe CHEK's Valuation Ratios CHEK's Financial Strength Ratios CHEK's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
Oncotelic Therapeutics Inc   252.91 %
Atara Biotherapeutics Inc   242.55 %
Traws Pharma inc   234.73 %
Scisparc Ltd  234.01 %
Petros Pharmaceuticals inc   233.39 %
Omada Health Inc   200.69 %
Interpace Biosciences Inc   198.59 %
Rigel Pharmaceuticals Inc  185.38 %
Icecure Medical Ltd  166.12 %
Silexion Therapeutics Corp  142.64 %
Heartflow Inc   142.09 %
Capforce Inc   140.91 %
Check Cap Ltd  120.45 %
Coherus Oncology inc   119.44 %
Kyntra Bio Inc   118.89 %
Lifemd Inc   105.75 %
Biocryst Pharmaceuticals Inc   88.36 %
Advanced Biomed Inc.  84.64 %
Earth Science Tech Inc   78.43 %
Exelixis Inc   71.31 %
Entera Bio Ltd   63.91 %
Tg Therapeutics Inc   63.77 %
Aurinia Pharmaceuticals Inc   56.37 %
Pulmatrix Inc   53.09 %
Novavax inc   51.88 %
Q32 Bio Inc   50.33 %
Idexx Laboratories Inc  48.69 %
Theravance Biopharma inc   46.03 %
Elite Pharmaceuticals Inc   45.80 %
Enlivex Therapeutics Ltd  45.75 %

Date modified: 2026-07-07T09:51:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.